These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

618 related articles for article (PubMed ID: 32974366)

  • 41. Pathology of nonalcoholic steatohepatitis.
    Brunt EM
    Hepatol Res; 2005 Oct; 33(2):68-71. PubMed ID: 16214395
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fatty Liver Disease and Hepatocellular Carcinoma: The Pathologist's View.
    Tiniakos DG; Maurício J; Reeves HL
    Adv Exp Med Biol; 2018; 1032():55-69. PubMed ID: 30362090
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ASH and NASH.
    Scaglioni F; Ciccia S; Marino M; Bedogni G; Bellentani S
    Dig Dis; 2011; 29(2):202-10. PubMed ID: 21734385
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality.
    Younossi Z; Henry L
    Gastroenterology; 2016 Jun; 150(8):1778-85. PubMed ID: 26980624
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Key Signaling in Alcohol-Associated Liver Disease: The Role of Bile Acids.
    Way GW; Jackson KG; Muscu SR; Zhou H
    Cells; 2022 Apr; 11(8):. PubMed ID: 35456053
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease.
    Hagström H; Hegmar H; Moreno C
    United European Gastroenterol J; 2024 Mar; 12(2):168-176. PubMed ID: 38381115
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Both alcoholic and non-alcoholic steatohepatitis association with cardiovascular risk and liver fibrosis.
    Sánchez-Jiménez BA; Brizuela-Alcántara D; Ramos-Ostos MH; Alva-López LF; Uribe-Esquivel M; Chávez-Tapia NC
    Alcohol; 2018 Jun; 69():63-67. PubMed ID: 29660603
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease.
    Boyle M; Masson S; Anstee QM
    J Hepatol; 2018 Feb; 68(2):251-267. PubMed ID: 29113910
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review.
    Ajmera VH; Terrault NA; Harrison SA
    Hepatology; 2017 Jun; 65(6):2090-2099. PubMed ID: 28100008
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Non-alcoholic fatty liver disease.
    Smith BW; Adams LA
    Crit Rev Clin Lab Sci; 2011; 48(3):97-113. PubMed ID: 21875310
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of diet and nutritional management in non-alcoholic fatty liver disease.
    Fan JG; Cao HX
    J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():81-7. PubMed ID: 24251710
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Interplay between Alcoholic Liver Disease, Obesity, and the Metabolic Syndrome.
    Malnick S; Maor Y
    Visc Med; 2020 Jun; 36(3):198-205. PubMed ID: 32775350
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Pediatric non-alcoholic fatty liver disease: recent advances and challenges].
    Poggiogalle E; Olivero G; Anania C; Ferraro F; Pacifico L
    Minerva Pediatr; 2010 Dec; 62(6):569-84. PubMed ID: 21042270
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Linking Non-alcoholic Fatty Liver Disease Severity With Metabolic Syndrome Features: An Integrative Study on Clinical and Radiological Fronts.
    Sukumar M; Vikram NK; Ranjan P; Pandey M; Bhalla AS; Ramakrishnan L; Javed D; Malhotra V; Prasad R; Mittal G
    Cureus; 2024 May; 16(5):e59788. PubMed ID: 38846245
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fibrosis and alcohol-related liver disease.
    Lackner C; Tiniakos D
    J Hepatol; 2019 Feb; 70(2):294-304. PubMed ID: 30658730
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Liver transplantation and non-alcoholic fatty liver disease.
    Zezos P; Renner EL
    World J Gastroenterol; 2014 Nov; 20(42):15532-8. PubMed ID: 25400437
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The diagnosis and treatment of non-alcoholic fatty liver disease.
    Altinbas A; Sowa JP; Hasenberg T; Canbay A
    Minerva Gastroenterol Dietol; 2015 Sep; 61(3):159-69. PubMed ID: 26080905
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metabolic syndrome and risk factors for non-alcoholic fatty liver disease.
    Souza MR; Diniz Mde F; Medeiros-Filho JE; Araújo MS
    Arq Gastroenterol; 2012; 49(1):89-96. PubMed ID: 22481692
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diabetes Mellitus Predicts Occurrence of Cirrhosis and Hepatocellular Cancer in Alcoholic Liver and Non-alcoholic Fatty Liver Diseases.
    Raff EJ; Kakati D; Bloomer JR; Shoreibah M; Rasheed K; Singal AK
    J Clin Transl Hepatol; 2015 Mar; 3(1):9-16. PubMed ID: 26356325
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical outcomes of non-alcoholic fatty liver disease: Polish-case control study.
    Kempiński R; Łukawska A; Krzyżanowski F; Ślósarz D; Poniewierka E
    Adv Clin Exp Med; 2019 Dec; 28(12):1615-1620. PubMed ID: 31025557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.